Clinical Trial Update: A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab [Phase 2]

View source ↗

Summary

Phase II trial evaluating pulsed reduced-dose-rate radiation therapy with bevacizumab for glioma. The study was terminated and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Glioma | Phase 2 | Status: TERMINATED | Results posted: 2026-03-25